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UVB Radiation-Mediated Inhibition of Contact
Hypersensitivity Reactions Is Dependent on the
Platelet-Activating Factor System
Qiwei Zhang1,2,6, Yongxue Yao1,2,6, Raymond L. Konger1,3, Anthony L. Sinn2, Shanbao Cai2,
Karen E. Pollok2,4 and Jeffrey B. Travers1,2,4,5
Through its ability to both induce immunosuppression and act as a carcinogen, UVB radiation plays a major role
in cutaneous malignancies. Recent studies have indicated that UVB-mediated inhibition of delayed-type
hypersensitivity reactions is mediated, in part, by the lipid mediator platelet-activating factor (PAF).
The objective of this study was to further define the mechanism by which UVB inhibits contact hypersensitivity
(CHS) reactions. UVB irradiation resulted in an inhibition of subsequent CHS to the chemical DNFB in wild-
type, but not in PAF-R-deficient mice. UVB-mediated inhibition of CHS was also blocked by a cyclooxygenase-2
(COX-2) inhibitor or a neutralizing antibody directed against IL-10. UVB irradiation upregulated IL-10 mRNA
levels in lymph nodes and spleen only to significant levels in PAF-R-expressing mice. Bone marrow
transplantation studies demonstrated that UVB-mediated immunomodulatory effects were dependent on
PAF-R-positive bone marrow. These studies suggest that UVB irradiation results in epidermal production of PAF
agonists, which then act on PAF-R-positive bone marrow-derived cells to upregulate IL-10 through COX-2-
generated prostaglandins.
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INTRODUCTION
UVB radiation (290–320 nm; UVB) is the most important
environmental carcinogen, and skin is the major target. Non-
melanoma skin cancer is the most common type of cancer
diagnosed, and UV radiation is the source (Kripke, 1977;
Carroll et al., 2003). In addition to its ability to damage DNA,
UVB radiation is immunosuppressive (Ullrich, 2005). UVB-
induced immunosuppression is divided into two distinct
types, local and systemic immunosuppression (Ullrich,
2005). Local immunosuppression is observed when UVB
irradiation to an area of skin results in the inability to sensitize
with an antigen in the UVB-irradiated area. Systemic
immunosuppression is produced when UVB irradiation to
an area results in the inability to sensitize with an antigen in
skin distant from the UVB-irradiated site. Experimental
studies with mice indicate that systemic immunosuppression
usually necessitates higher doses of UVB than local
immunosuppression. Compelling findings from a multitude
of sources, including animal model systems and human
patients, especially transplant patients, have confirmed that
the immunosuppressive effects of UV are a major risk factor
in the development of these skin cancers (Ullrich, 2002;
Young and Wikonkal, 2007).
Recent studies have implicated UVB-induced soluble
mediators derived from human keratinocytes in systemic
immunosuppression. The lipid mediator platelet-activating
factor (1-O-alkyl-2-acetyl glycerophosphocholine, PAF) is
one of the mediators that have been implicated. PAF is an
inflammatory phospholipid mediator that exerts its effects
through a single specific G-protein-coupled receptor, the PAF
receptor (PAF-R) (Ishii et al., 2002). The PAF-R is expressed
by cells of the innate immune system, but also by
keratinocytes of the skin (Travers et al., 1995). PAF is
synthesized in response to diverse stimuli including cyto-
kines, endotoxin, and Ca2þ ionophores (Travers et al., 1996).
Notably, direct damage to keratinocytes by either heat or
cold stimuli results in significant PAF production (Alappatt
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et al., 2000). PAF is produced enzymatically, yet PAF and
sn-2 short-chained acyl glycerophosphocholines (GPCs) with
PAF-R agonistic activity can also be produced through free
radical-mediated damage (Marathe et al., 2000).
Through its ability to act as a potent pro-oxidative stressor
(Peus et al., 1998), UVB has been demonstrated to trigger
production of PAF and oxidized GPCs (ox-GPC) with PAF-R
agonistic activity (Walterscheid et al., 2002; Marathe et al.,
2005). Several lines of evidence have implicated these UVB-
generated PAF agonists in UVB-mediated systemic immuno-
suppression. First, pretreatment of mice with a series of PAF-R
antagonists inhibits UVB-mediated inhibition of delayed-type
hypersensitivity (DTH) reactions to Candida albicans
(Walterscheid et al., 2002). This inhibition of DTH was
mimicked by intraperitoneal injection of PAF or UVB-
irradiated GPC (Walterscheid et al., 2002). Second, inhibition
of DTH to C. albicans induced by topical psoralen and UVA
or by a solar-simulator UV source was observed in wild-type,
but not in PAF-R-deficient mice (Wolf et al., 2006). Finally, in
a model of contact hypersensitivity (CHS) to the chemical
DNFB, intraperitoneal injection of the PAF-R agonist
1-hexadecyl-2-N-methylcarbamoyl GPC (CPAF) inhibited
both the sensitization and elicitation phases in wild-type
but had no effect in PAF-R-negative mice (Zhang et al., 2005).
Significantly, COX-2 inhibitors and IL-10-neutralizing anti-
body blocked PAF-mediated immunomodulatory effects
(Walterscheid et al., 2002; Zhang et al., 2005). These studies
indicate that UVB-generated PAF/ox-GPC results in a
potentially complex series of events involving COX-2 and
IL-10 resulting in an inhibition of DTH reactions.
The objective of this study was to characterize the role of
the PAF system in UVB-mediated systemic immunosuppres-
sion using the model system of CHS to the chemical DNFB.
This study confirms the importance of PAF agonists in this
process and indicates that UVB generates PAF agonists,
which then act on PAF-R-positive bone marrow-derived
immune cells to inhibit DTH reactions through IL-10.
Inasmuch as the immunomodulatory effects of UVB are felt
to be important in its carcinogenic as well as therapeutic
effects, characterization of this process could have significant
clinical benefit.
RESULTS
Importance of PAF-R in UVB-mediated inhibition of contact
hypersensitivity
UVB irradiation induces an inhibition of DTH reactions.
Thus, our earlier studies assessed the role of PAF-R in the
UVB-mediated inhibition of CHS using PAF-R-deficient mice
(Ishii et al., 1998). In these studies, an approximately
2.52.5 cm area of shaved back skin was treated with
7.5 kJm2 UVB radiation. Identically treated mice without
UVB served as controls (sham). Five days after mock or UVB
irradiation, unirradiated back skin approximately 3 cm away
from the irradiated site was sensitized to the chemical
compound DNFB. Nine days after DNFB sensitization, the
dorsal sides of ears were treated with DNFB or vehicle
control. Punch biopsies were taken from ears 24 hours later
and inflammation assessed by weighing and comparing
DNFB with vehicle-painted biopsies. Treatment of murine
ears with DNFB without previous sensitization did not result
in significant inflammation (as measured by ear biopsy
weight) at 24 hours (data not shown). As shown in Figure 1,
there was no difference in the CHS reactions between wild-
type and PAF-R/ mice. Intraperitoneal injection of the
metabolically stable PAF-R agonist CPAF followed 5 days
later by DNFB sensitization resulted in an inhibition of CHS
to DNFB only in wild-type mice (Figure 1a). UVB treatment
also inhibited subsequent CHS reactions to DNFB in
wild-type, but not in PAF-R/ mice (Figure 1b). These
studies demonstrate involvement of the PAF system in UVB-
mediated inhibition of CHS.
Involvement of cyclooxygenase-2 and IL-10 in UVB-mediated
inhibition of contact hypersensitivity
Earlier studies have implicated IL-10 in immunosuppressive
effects of UVB (Shreedhar et al., 1998; Nghiem et al., 2002).
It is to be noted that PAF-R activation has been shown to
stimulate IL-10 production through a COX-2-dependent
process in the murine keratinocyte cell line PAM 212
(Walterscheid et al., 2002). Intradermal injection of CPAF
also results in epidermal IL-10 production in PAF-R-expres-
sing, but not in PAF-R-deficient mice (Zhang et al., 2005).
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Figure 1. Effect of UVB and CPAF on CHS in wild-type vs PAF-R/ mice.
Wild-type and PAF-R/ mice were treated with either (a) intraperitoneal
injection of 250 ng of the PAF-R agonist CPAF or vehicle control, or (b) local
irradiation with 0 (sham) or 7,500 Jm2 UVB. Mice were then sensitized to
DNFB and elicitation reactions performed on the dorsal ears as outlined in
Materials and Methods. At 24 hours after elicitation reactions, 5mm punch
biopsies were obtained from the ears and weighed. The data listed are the
mean±SEM difference in ear biopsy weights from n¼ 6 mice. *Statistically
(Po0.05) significant changes.
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Thus, IL-10 could mediate PAF-R-mediated immunomodula-
tory effects.
The succeeding studies tested the hypothesis that UVB-
generated PAF from the skin results in COX-2-mediated
prostaglandins, which then induce IL-10 production mediat-
ing UVB inhibitory effects on CHS. In those studies we tested
the effect of the COX-2 antagonist SC236 and a neutralizing
antibody against IL-10 on UVB-mediated inhibition of CHS.
As shown in Figure 2, pretreatment with SC236 has no effect
on CHS in unirradiated mice, but blocks the inhibitory effects
of both UVB and CPAF. To confirm that IL-10 is involved in
UVB-mediated suppression of CHS reactions, we tested the
ability of a neutralizing antibody against IL-10 (Nghiem et al.,
2002) to block CPAF- and UVB-induced inhibition of DNFB
reactions. As shown in Figure 3, systemic treatment with
neutralizing anti-IL-10 antibody blocked the CPAF- (Figure
3a) and UVB- (Figure 3b) induced inhibitory effects on CHS
in wild-type mice. These studies provide support for the
notion that COX-2 metabolites and IL-10 are downstream
mediators of PAF in UVB-mediated inhibition of CHS.
Evidence that immunocyte IL-10 mediates UVB-mediated
systemic immunosuppression
UVB-mediated PAF and PAF-like lipids (for example,
ox-GPC) could potentially interact with epidermal keratino-
cytes (Pei et al., 1998; Walterscheid et al., 2002), or PAF-R
agonists could interact with bone marrow-derived cells
including dendritic cells or T/B cells (Travers et al., 1989;
Mazer et al., 1992; Sozzani et al., 1997) to induce COX-2
and IL-10. The succeeding studies were designed to assess
whether the IL-10 induction in response to UVB was derived
from skin or lymphoid organs. To that end, wild-type and
PAF-R/ mice were irradiated with UVB as per our
protocol, and irradiated skin, nearby unirradiated skin, lymph
nodes, or spleen were harvested at 24, 48, or 72 hours, and
IL-10 mRNA measured by quantitative real-time reverse
transcriptase-PCR (qRT-PCR). As depicted in Figure 4, UVB
irradiation resulted in an upregulation of IL-10 mRNA levels
in lymph nodes and spleen of wild-type, but not in PAF-R/
mice at 24 hours. IL-10 mRNA levels were only slightly
increased above baseline levels in wild-type, but again none
was detected in PAF-R/mice at 48 hours (data not shown).
IL-10 mRNA was not increased in lymph nodes or spleen at
72 hours. Notably, UVB irradiation did not result in increased
levels of IL-10 mRNA levels in directly irradiated nor in
nearby unirradiated skin at any of the time points examined
(data not shown).
The succeeding studies attempted to evaluate which cells
in lymph nodes expressed IL-10. To that end, an area of distal
back skin of wild-type and PAF-R/ mice were treated with
7.5 kJm2 UVB radiation, and 24 hours later the groin
draining lymph nodes were harvested. Cytokine expression
in enriched populations of dendritic cells, macrophages,
B cells, and CD4 and CD8 T cells was measured by qRT-PCR.
As shown in Figure 5a, baseline IL-10 expression was seen in
lymph node cells from both wild-type and PAF-R/ mice.
Of the cell types that appear responsible for the IL-10
production, dendritic cells and monocytes were found to
have the highest expression, with lesser amounts seen in CD4
T cells. Immunocyte production of IL-12 was also examined,
as this cytokine, like IL-18, has protective effects against
UVB-mediated immunosuppression through its ability to
protect against DNA damage (Schwarz et al., 2006). As
indicated in Figure 5b, however, IL-12 mRNA levels were not
altered after UVB irradiation in both wild-type and PAF-R/
immunocytes. In addition, levels of the pleiotropic cytokine
tumor necrosis factor-a were not induced differentially
between wild-type and PAF-R/ immunocytes (Figure 5c).
These studies suggest that the source of the IL-10 in this
model of UVB-induced systemic immunosuppression is from
immune cells, not from keratinocytes.
PAF-R-expressing immunocytes are responsible for
UVB-mediated immunosuppressive effects
The present study suggests that UVB-generated PAF from the
skin stimulates IL-10 production in lymphoid cells. This
would indicate two possibilities for how UVB-generated PAF
agonists act: (1) PAF-R agonists act on keratinocytes to
stimulate COX-2 and that prostaglandins then mediate the
IL-10 production in bone marrow-derived immunocytes or (2)
PAF-R agonists act directly on bone marrow-derived
immunocytes to upregulate IL-10 in a COX-2-dependent
manner.
To test whether the PAF-R-responsive cells are skin- or
bone marrow-derived, PAF-R/ mice were transplanted
with PAF-R-positive bone marrow, and vice versa, to create
chimeric mice with respect to PAF-R and bone marrow. As
shown in Figure 6, bone marrow replacement of PAF-R/
mice with PAF-R-positive cells restored the inhibitory effects
of UVB on CHS. Similarly, PAF-R-positive mice transplanted
with PAF-R/ bone marrow did not respond to these
immunomodulatory effects of UVB (Figure 6). These studies,
along with the IL-10 studies in Figures 4 and 5a, indicate that
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Figure 2. Effect of a COX-2 inhibitor on CPAF- and UVB-mediated inhibition
of CHS in wild-type mice. Wild-type mice were pretreated with
intraperitoneal injection of 200 ng of the COX-2 antagonist SC-236 or vehicle
(control) and the mice treated with intraperitoneal injection of 250 ng CPAF
or local irradiation with 0 (sham) or 7,500 Jm2 UVB. Mice were then
sensitized to DNFB and elicitation reactions performed on the dorsal ears as
outlined in Materials and Methods. At 24 hours after elicitation reactions,
5mm punch biopsies were obtained from the ears and weighed. The data
listed are the mean±SEM difference in ear biopsy weights from n¼6 mice.
*Statistically (Po0.05) significant changes.
1782 Journal of Investigative Dermatology (2008), Volume 128
Q Zhang et al.
PAF and UVB-Mediated Immunosuppression
the PAF-R-positive cells critical for UVB-mediated IL-10
production and inhibition of CHS are bone marrow-derived,
not keratinocytes.
DISCUSSION
This study indicates the importance of the PAF system in
UVB-mediated inhibition of murine CHS. The lack of
responsiveness of PAF-R-deficient mice to the inhibitory
effects of UVB on CHS to the chemical DNFB and the ability
of the PAF-R agonist CPAF to mimic UVB (Figure 1) provide
compelling evidence implicating PAF in this process. These
studies confirm our previous findings that intraperitoneal
injection of the PAF agonist CPAF inhibits CHS to DNFB in
wild-type, but not in PAF-R-deficient mice (Zhang et al.,
2005). These studies also fit with the findings by Ullrich and
colleagues that PAF-R antagonists block UVB-mediated DTH
reactions to subcutaneous killed C. albicans (Walterscheid
et al., 2002). In addition, UV irradiation using a solar
simulator was reported to inhibit DTH to C. albicans in wild-
type, but not in PAF-R/ mice (Wolf et al., 2006).
UVB-mediated systemic immunosuppressive effects have
been linked to IL-10. The ability of PAF-R activation to
stimulate production of the powerful TH2 cytokine IL-10 in
epidermal and other cell types provides a mechanism by
which the PAF system can inhibit TH1 and enhance TH2
responses (Walterscheid et al., 2002). The importance of
IL-10 in allergic skin diseases has been identified using
tools such as IL-10/ mice, whose phenotype includes
blunting of TH2 and enhanced TH1-associated reactions
(Yang et al., 1999). Our findings that UVB irradiation of
murine skin in PAF-R-positive mice results in detectable
levels of IL-10 mRNA in lymph nodes/spleen and that
UVB- and CPAF-mediated inhibition of murine CHS is
inhibited by a neutralizing antibody against IL-10 both
indicate involvement of IL-10 in this process. Although
UVB irradiation of epithelial cells has been shown to induce
IL-10 production (Moodycliffe et al., 1996; Walterscheid
et al., 2002), our studies suggest that immunocyte IL-10
probably plays a more important role in UVB-mediated
systemic immunosuppression.
As UVB irradiation does not pass significantly through the
epidermis (Garmyn and Yarosh, 2007), the initial target
for UVB must reside in the most superficial aspects of the
skin. Thus, UVB interacting with epidermal cells then puts
into play the processes resulting in UVB-mediated systemic
immunosuppression. The exact process and mediators
involved have not been fully characterized, yet accumula-
ting evidence including these studies implicates the PAF
system.
The synthetic pathway for PAF consists of two enzymes; a
phospholipase A2 that generates the lysolipid backbone by
releasing the sn-2 fatty acyl residue from alkyl phosphatidyl-
choline and PAF acetyltransferase activity that transfers an
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Figure 3. Effect of a neutralizing anti-IL-10 antibody on CPAF- and UVB-
mediated inhibition of CHS in wild-type mice. Wild-type mice were treated
with (a) 250 ng CPAF or control vehicle or (b) local irradiation with 0 (sham)
or 7,500 Jm2 UVB. Four and 24 hours after UV irradiation, the mice were
injected intraperitoneally with 100 mg neutralizing rat anti-mouse IL-10
antibodies or 100mg rat IgG1 antibody control or BSA vehicle control. Mice
were then sensitized to DNFB and elicitation reactions performed on the
dorsal ears as outlined in Materials and Methods. At 24 hours after elicitation
reactions, 5mm punch biopsies were obtained from the ears and weighed.
The data listed are the mean±SEM difference in ear biopsy weights from
n¼ 6 mice. *Statistically (Po0.05) significant changes.
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Figure 4. IL-10 expression in groin lymph nodes and spleen after UVB
irradiation of mouse back skin. Wild-type and PAF-R/ mice were shaved
and the lower backs were exposed to 7,500 Jm2 UVB irradiation. The
control mice were shaved but sham irradiated. Twenty-four hours after
exposure, the groin lymph nodes and spleen were taken and homogenized
and total RNA was isolated. RNA was reverse transcribed and qRT-PCR
performed with the IL-10 primer kit (reference positions 319–339) on
SmartCycler PCR system with SmartCycler 1.2 software. The expression levels
of IL-10 were normalized to the expression levels of 18S. The data listed are
the mean±SEM in IL-10/18S from n¼4 mice. *Statistically (Po0.05)
significant changes in comparison to similarly treated wild-type mice. ND,
not detectable.
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acetyl residue from acetyl-CoA to this newly generated
lysolipid (Prescott et al., 2000). Both activities are tightly
regulated, with increased intracellular Ca2þ being the
premier agent for their activation.
Ligands that activate the PAF-R are generated in a second
way, and this route is not subject to cellular control. The alkyl
phospholipid pool is enriched at the sn-2 position with
arachidonoyl residues, a source of lyso-PAF and arachidonate
for prostanoid and leukotriene synthesis, which as a
polyunsaturated fatty acid is susceptible to non-enzymatic
oxidation. Oxidation of esterified fatty acyl residues intro-
duces oxy functions, rearranges bonds, and fragments
carbon–carbon bonds by b-scission that generate a myriad
of reaction products (Frankel, 1984). Among these are a series
of phospholipids with oxidatively fragmented sn-2 acyl
residues that terminate with either an o-oxy function or a
methyl group. The latter series is one carbon atom shorter
than the o-oxy series, as expected from the b-scission
reaction. Among the phospholipid reaction products are
those that are ligands for the PAF-R. The most potent of
the non-enzymatically generated PAF analogs are native PAF
as well as the butanoyl (C4-PAF) and butenoyl (C4:1-PAF)
species, which are one tenth as potent as PAF (Heery et al.,
1995).
Previous studies from our group have used mass spectro-
metry to identify native PAF as well as ox-GPCs including
butanoyl and butenoyl PAF species produced in response to
UVB in the human epithelial cell line KB (Marathe et al.,
2005). Moreover, UVB irradiation of the precursor phospho-
lipid 1-hexadecyl-2-arachidonoyl GPC in a cell-free system
generates these same products, consistent with a non-
enzymatic process (Marathe et al., 2005).
This study fits with the hypothesis that UVB, through its ability
to act as a pro-oxidative stressor, generates PAF and ox-GPCs,
which then act on bone marrow-derived immunocytes to
generate IL-10 through COX-2-produced prostaglandins. Com-
patible with this hypothesis, recent studies by Matsumura et al.
(2006) found that transferring lymph node cells from UV-
irradiated, FITC-sensitized mice into normal recipients trans-
ferred immune tolerance. Elegant studies by this group demon-
strated that the cell responsible was a CD19þ , B220þ B cell.
These studies examining the transfer of UVB-mediated tolerance
indicated that inhibition of both the serotonin and PAF-R systems
were necessary to block the production of these B cells
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Figure 5. Cytokine expression in immunocytes from lymph nodes after UVB irradiation of mouse back skin. Wild-type and PAF-R/ mice were shaved
and the lower backs exposed to 7,500 Jm2 UVB irradiation. The control mice were shaved but sham irradiated. Twenty-four hours after exposure, the
groin lymph nodes were obtained and cell populations purified as described in Materials and Methods. Total RNA was isolated from enriched different cell types
and cDNA were synthesized and qRT-PCR was performed by the comparative threshold cycle (DCT) method for (a) IL-10, (b) IL-12, and (c) TNF-a and
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The data listed are the mean±SEM mRNA from two separate experiments of cell types
derived from pooled lymph nodes from five mice with the PCRs conducted in triplicate. DC, dendritic cells; MQ, macrophages. Po0.05 compared to self
non-UVB control; Po0.05 compared to self non-UVB control and KO counterpart.
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(Matsumura et al., 2006). Yet, the authors also reported
previously that use of PAF-R antagonists alone were adequate
to block UVB-mediated immunosuppression (Walterscheid
et al., 2002), indicating differences in UVB-mediated immuno-
suppression and tolerance. It should be pointed out that this
study does not examine which cell type or mediators induces
tolerance, but instead the role of the PAF system in systemic
immunosuppression. Although the PAF-R status of the CD19þ ,
B220þ B cell implicated in tolerance has not been assessed
(Matsumura et al., 2006), B cells have been described as
expressing functional PAF-Rs, unlike T cells (Travers et al., 1989;
Mazer et al., 1992). However, other PAF-R-positive immuno-
cytes including monocytes and dendritic cells (Sozzani et al.,
1997) could also react to skin-derived PAF agonists. Although
PAF-R agonists including native PAF and ox-GPCs have very
short half-lives, it is indeed possible that these agonists could
have systemic effects. For example, PAF-R agonists have been
detected in blood of hamsters (Lehr et al., 1997) and humans
(Imaizumi et al., 1991) exposed to the pro-oxidative stressor
cigarette smoke.
In summary, these studies indicate that the target for the
PAF agonists that appear to be critical for UVB-mediated
inhibition of murine CHS is bone marrow-derived cells.
These data also suggest that the IL-10 involved in UVB-
mediated systemic immunosuppression does not come from
the skin, but instead from immunocytes. Inasmuch as UVB-
mediated immunosuppressive effects have been implicated in
processes as diverse as carcinogenesis to recrudescence of
herpes simplex virus, characterization of the mediators
involved has important clinical implications.
MATERIALS AND METHODS
Reagents
All chemicals were obtained from Sigma (St Louis, MO) unless
indicated otherwise.
Mice
PAF-R/ mice on a C57BL6 background generated as described
previously were a kind gift of Ishii et al. (1998). B6.SJL-PtprcaPep3b/
BoyJ (BoyJ) mice were obtained from the Indiana University Cancer
Center, Stem Cell Transplant Core Breeding Colony (Indianapolis,
IN). Age (8–12 week)-matched PAF-Rþ /þ C57BL6 wild-type mice
were used as controls. All mice were housed in a pathogen-free
environment, and studies were approved by the Animal Care and
Use Committee of Indiana University School of Medicine.
Contact hypersensitivity reactions
Contact hypersensitivity to DNFB was conducted as described
previously (Zhang et al., 2005) with minor modifications. Briefly, to
evaluate the effect of CPAF on sensitization reactions, both wild-type
and PAF-R/ mice were injected intraperitoneally with 50 ml CPAF
(250 ng), or 50 ml BSA vehicle alone. After 5 days, the back skin of
mouse was shaved and 25ml of 0.5% DNFB in acetone:olive oil
(4:1, v/v) applied to an area approximately 1 1 cm. Nine days later,
one of the dorsal sides of ears was challenged with painting of 10 ml
of 0.5% DNFB and the other ear painted with vehicle. After
24 hours, 5mm punch biopsies were obtained from the ears
and weighed. Our previous studies have demonstrated that
measurement of weights of punch biopsies from ears correlated
with measurement of ear thickness with calipers (Petersen et al.,
2002), and our laboratory prefers this methodology due to greater
reproducibility in our hands. For studies assessing the ability of UVB
to affect CHS, the back skin of mice was shaved, and the
anesthetized mouse was draped to allow an area of 2.5 2.5 cm
of distal back skin exposed to UVB. The UV source was a Philips
(Surrey, UK) F20T12/UV-B lamp (270–390 nm, containing 2.6%
UVC, 43.6% UVB, and 53.8% UVA). The intensity of the UVB
source was measured before each experiment using an IL1700
radiometer and a SED240 UVB detector (International Light,
Newburyport, MA) at a distance of 8 cm from the UVB source to
mice. Five days after UVB irradiation of the distal back skin, an area
of 1 1 cm of unirradiated back skin approximately 3 cm cephalic
was sensitized with DNFB as outlined above.
To evaluate the effects of COX-2 or IL-10 in the CPAF- or UVB-
induced suppression of CHS, the mice were first injected intraper-
itoneally with 250 ng CPAF or 200 ng COX-2 antagonist SC236 or
BSA vehicle control or UVB irradiated as above; 4 and 24 hours
later, the mice were twice injected intraperitoneally with 100mg of
neutralizing rat anti-mouse IL-10 antibody (BD Pharmingen, San
Diego, CA) (Nghiem et al., 2002) or 100 mg rat IgG1 (eBioscience,
San Diego, CA) as antibody control or BSA vehicle control; after
5 days, mice were sensitized with DNFB. Nine days later, the mice
were challenged by painting 10 ml 0.5% DNFB on one ear and
vehicle control on the other. Five millimeter punch biopsies were
performed 24 hours later and weighed.
IL-10 measurements
RNA preparation, reverse transcription and quantitative real-time
PCR (QRT2-PCR) were performed as described previously (Travers
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Figure 6. Effect of UVB on CHS in PAF-R chimeric mice. Wild-type (BoyJ),
PAF-R/, or two groups of chimeric mice with PAF-R-positive bone marrow
in a PAF-R-negative host and PAF-R-negative bone marrow in a PAF-R-
positive host or a transplantation control (PAF-R-positive bone marrow in a
PAF-R-negative host) were treated with local irradiation with 0 (sham) or
7,500 Jm2 UVB. Mice were then sensitized to DNFB and elicitation
reactions performed on the dorsal ears as outlined in Materials and Methods.
At 24 hours after elicitation reactions, 5mm punch biopsies were obtained
from the ears and weighed. The data listed are the mean±SEM difference in
ear biopsy weights. Parentheses indicate numbers of mice used in each
treatment. *Statistically (Po0.05) significant changes.
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et al., 2008). Tissue was homogenized and total RNA was isolated
with RNeasy Mini Kit (Qiagen Sciences, Valencia, CA), as described
by the manufacturer. RNA was reverse transcribed with Reaction-
Ready First Strand cDNA Synthesis Kit (SuperArray, Frederick, MD).
The quantitative real-time PCR was performed with the IL-10 primer
kit (reference positions 319–339) obtained from SuperArray on
SmartCycler PCR system with SmartCycler 1.2 software (Cepheid,
Sunnyvale, CA) at 95 1C for 15minutes and 40 cycles of 95 1C,
30 seconds; 55 1C, 30 seconds; and 721C, 30 seconds, as described
by the manufacturer. The expression levels of IL-10 were normalized
to the expression levels of housekeeping gene 18S.
Measurement of immunocyte cytokines
To identify the cell type(s) of IL-10-producing cells in the lymph
nodes upon UVB radiation, the shaved lower back skin of wild-type
and PAF-R/ mice (five mice per group) was mock- or UVB-
radiated (7,500 Jm2). Draining inguinal lymph nodes were
harvested 24 hours later and pooled together to prepare single
suspension cells. CD11c-positive dendritic cells were first isolated
from total lymph node cells using the anti-CD11c magnetic beads
(Miltenyi Biotech, Auburn, CA). The CD11c-negative flow was
further used to isolate B cells, macrophages, CD4 and CD8 T cells
with anti-CD19, anti-CD11b, anti-CD4, and anti-CD8 magnetic
beads, respectively.
Total RNA was isolated from enriched different cell types and
cDNA was synthesized. qRT-PCR was performed by the comparative
threshold cycle (DCT) method and normalized to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). The primers used for IL-10,
IL-12p40, tumor necrosis factor-a, and GAPDH were as described
(Yee et al., 2005; Zhao et al., 2006).
Bone marrow transplantation studies
Chimeric mice were generated as described previously (Kreklau
et al., 2003). Briefly, bone marrow cells from PAF-R/ mice
(CD45.2þ ) were harvested and transplanted into lethally irradiated
PAF-Rþ /þ BoyJ mice (CD45.1) at 4 106 cells per mouse.
Irradiation was delivered as a split dose of 700 cGy followed by
400 cGy delivered 4 hours later. The peripheral blood was harvested
4 months later through the tail vein, and the contribution of the PAF-
R/ cells (CD45.2þ ) and the host cells (CD45.1þ ) were analyzed
by flow cytometry. A phycoerthryin-conjugated anti-mouse CD45.1
antibody (clone A20) and a PerCp-Cy5.5-conjugated anti-mouse
CD45.2 antibody (clone 104) were purchased from BD Pharmingen
(Auburn, CA) for detection of CD45.1þ and CD45.2þ murine
cells. In another group of transplants, PAF-Rþ /þ BoyJ bone marrow
was transplanted into lethally irradiated PAF-R/ or PAF-Rþ /þ
BoyJ mice and reconstitution analyzed as described above.
Data analysis
Data from the murine studies are presented as mean±SEM. Student’s
t-tests were used to assess statistical significance for differences in
means. Significance was set at Po0.05.
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